Currently authorised products

The current authorised products
Territory Product name MA holder VM number Active substances Target species Distribution category Aligned product
Great Britain Nexgard Spectra 150 mg / 30 mg Chewable Tablets for Dogs >30–60 kg Boehringer Ingelheim Vetmedica Gmbh 04491/5031
  • Afoxolaner
  • Milbemycin Oxime (A3 and A4)
  • Dogs
POM-V
Great Britain RenuTend Suspension for Injection for Horses Boehringer Ingelheim Vetmedica GmbH 04491/5064
  • Tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells (tpMSCs)
  • Horses
POM-V
Northern Ireland Arti-Cell Forte Suspension for Injection for Horses Boehringer Ingelheim Vetmedica GmbH EU/2/18/228/001
  • Chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
  • Horses
POM-V
Northern Ireland Eurican Herpes 205 Powder and Solvent for Emulsion for Injection Boehringer Ingelheim Vetmedica Gmbh EU/2/01/029/001-003
  • Canine herpesvirus
  • Dogs
POM-V
Northern Ireland Frontpro 11 mg Chewable Tablets for Dogs 2–4 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/19/240/001-004
  • Afoxolaner
  • Dogs
NFA-VPS
Northern Ireland Frontpro 136 mg Chewable Tablets for Dogs >25–50 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/19/240/013-016
  • Afoxolaner
  • Dogs
NFA-VPS
Northern Ireland Frontpro 28 mg Chewable Tablets for Dogs >4–10 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/19/240/005-008
  • Afoxolaner
  • Dogs
NFA-VPS
Northern Ireland Frontpro 68 mg Chewable Tablets for Dogs >10–25 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/19/240/009-012
  • Afoxolaner
  • Dogs
NFA-VPS
Northern Ireland NexGard 11 mg Chewable Tablets for Dogs 2-4 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/13/159/001-003,013,017
  • Afoxolaner
  • Dogs
POM-V
Northern Ireland NexGard 136 mg Chewable Tablets for Dogs >25-50 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/13/159/010-012,016,020
  • Afoxolaner
  • Dogs
POM-V
Northern Ireland NexGard 28 mg Chewable Tablets for Dogs >4-10 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/13/159/004-006,014,018
  • Afoxolaner
  • Dogs
POM-V
Northern Ireland NexGard 68 mg Chewable Tablets for Dogs >10-25 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/13/159/007-009,015,019
  • Afoxolaner
  • Dogs
POM-V
Northern Ireland Nexgard Spectra 150 mg / 30 mg Chewable Tablets for dogs >30–60 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/14/177/013-015,020
  • Afoxolaner
  • Milbemycin Oxime (A3 and A4)
  • Dogs
POM-V
Northern Ireland Nexgard Spectra 19 mg / 4 mg Chewable Tablets for Dogs >3.5–7.5 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/14/177/004-006,017
  • Afoxolaner
  • Milbemycin Oxime (A3 and A4)
  • Dogs
POM-V
Northern Ireland Nexgard Spectra 38 mg / 8 mg Chewable Tablets for Dogs >7.5–15 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/14/177/007-009,018
  • Afoxolaner
  • Milbemycin Oxime (A3 and A4)
  • Dogs
POM-V
Northern Ireland Nexgard Spectra 75 mg / 15 mg Chewable Tablets for Dogs >15–30 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/14/177/010-012,019
  • Afoxolaner
  • Milbemycin Oxime (A3 and A4)
  • Dogs
POM-V
Northern Ireland Nexgard Spectra 9 mg / 2 mg Chewable Tablets for Dogs 2–3.5 kg Boehringer Ingelheim Vetmedica Gmbh EU/2/14/177/001-003,016
  • Afoxolaner
  • Milbemycin Oxime (A3 and A4)
  • Dogs
POM-V
Northern Ireland PREVEXXION RN+HVT+IBD Concentrate and Solvent for Suspension for Injection Boehringer Ingelheim Vetmedica Gmbh EU/2/20/255/001-003
  • Marek's disease virus
  • Turkey herpesvirus
  • Chickens
POM-V
Northern Ireland Purevax RCP Boehringer Ingelheim Vetmedica Gmbh EU/2/04/052/001-004
  • Feline calicivirus
  • Feline panleukopenia virus
  • Feline viral rhinotracheitis virus
  • Cats
POM-V
Great Britain Arti-Cell Forte Suspension for Injection for Horses Boehringer Ingelheim Vetmedica GmbH 04491/5062
  • Chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
  • Horses
POM-V